Ind-Swift Laboratories Ltd has plans to launch 20 new drugs in the market by the year 2004-2005. Out of these 20 drugs, nine drugs are planned to be launched in the next financial year, the Company informed BSE. The new products are from the high growth therapeutic segments of anti-cancer, anti-diabetic, cardiovascular, neurological disorders and anti-diarroeheal.
Clinical trials and Bio-equivalence studies for the said products for obtaining necessary DCGI approvals is already in process, which would expedite the commercial launch of these products.